The third drug, efavirenz, is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Each drug class works against HIV in a different way. You should take efavirenz/emtricitabine/tenofovir ...
The fixed-dose combination was first approved as Atripla in the United States in 2006 and in the European Union in late 2007. Numerous generic versions are also available. Branded Atripla will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback